Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Dec 2021 07:00 AM
RNS
Q-Bot Investment and Share Acquisition
20 Dec 2021 07:00 AM
RNS
Acquisition of majority stake in Cetromed
13 Dec 2021 07:00 AM
RNS
Martlet Capital Update
06 Dec 2021 02:53 PM
RNS
PDS Phase 2 Clinical Trial Update
26 Nov 2021 07:00 AM
RNS
$1million investment in portfolio company, EpiBone
10 Nov 2021 01:58 PM
RNS
PDS Reports Q3 2021 Results & Business Update
04 Nov 2021 07:00 AM
RNS
Sofant Signs EUR7.3m ESA Contract
01 Nov 2021 02:16 PM
RNS
PDS to License Novel Proteins for Flu Vaccine
26 Oct 2021 07:00 AM
RNS
EMV Capital Participates in £843k Sofant Funding
22 Oct 2021 11:18 AM
RNS
ProAxsis announces the approval of a key US patent
22 Oct 2021 09:04 AM
RNS
Holding(s) in Company
21 Oct 2021 04:40 PM
RNS
Second Price Monitoring Extn
21 Oct 2021 04:35 PM
RNS
Price Monitoring Extension
21 Oct 2021 02:17 PM
RNS
PDS Phase 2 Clinical Trial Update
05 Oct 2021 07:00 AM
RNS
PDS Phase 2 Clinical Trial Update
04 Oct 2021 07:00 AM
RNS
Investor Presentations
30 Sep 2021 10:22 AM
RNS
Holding(s) in Company
29 Sep 2021 07:00 AM
RNS
Grant of Options to Directors
29 Sep 2021 07:00 AM
RNS
Interim Results
20 Sep 2021 07:00 AM
RNS
Notice of Results and Analyst Briefing
16 Sep 2021 07:00 AM
RNS
Investment in Martlet Capital Limited
09 Aug 2021 05:59 PM
RNS
Holding(s) in Company
30 Jul 2021 09:12 AM
RNS
Holding(s) in Company
26 Jul 2021 04:25 PM
RNS
Holding(s) in Company
22 Jul 2021 04:29 PM
RNS
Holding(s) in Company
20 Jul 2021 02:05 PM
RNS
Second Price Monitoring Extn
20 Jul 2021 02:00 PM
RNS
Price Monitoring Extension
16 Jul 2021 10:35 AM
RNS
Director/PDMR Shareholding
01 Jul 2021 12:08 PM
RNS
Holding(s) in Company
30 Jun 2021 03:42 PM
RNS
Holding(s) in Company
30 Jun 2021 10:29 AM
RNS
Holding(s) in Company
30 Jun 2021 10:27 AM
RNS
Holding(s) in Company
28 Jun 2021 03:18 PM
RNS
Result of General Meeting, TVR & PDMR Dealings
22 Jun 2021 07:00 AM
RNS
PDS Announces Closing of c. $52m Public Offering
16 Jun 2021 07:00 AM
RNS
NSCI Participates in $45m PDS Equity Issue
15 Jun 2021 07:00 AM
RNS
PDS announces proposed offering of common stock
10 Jun 2021 12:56 PM
RNS
Result of Placing and Total Voting Rights
10 Jun 2021 07:00 AM
RNS
Proposed Placing
09 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
09 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
09 Jun 2021 02:05 PM
RNS
Second Price Monitoring Extn
09 Jun 2021 02:00 PM
RNS
Price Monitoring Extension
08 Jun 2021 04:36 PM
RNS
Price Monitoring Extension
08 Jun 2021 01:40 PM
RNS
PDS Announces Release of PDS0101 Interim Data
08 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
08 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
07 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
07 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
07 Jun 2021 02:06 PM
RNS
Second Price Monitoring Extn
07 Jun 2021 02:00 PM
RNS
Price Monitoring Extension

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings